Summit Healthcare Acquisition Corp. Warrant
SMIHW
SMIHW was delisted on the 16th of March, 2023.
24 hedge funds and large institutions have $18.9M invested in Summit Healthcare Acquisition Corp. Warrant in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
26% more funds holding
Funds holding: 19 → 24 (+5)
11% more capital invested
Capital invested by funds: $17.1M → $18.9M (+$1.82M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Athos Capital
Hong Kong
|
+$24.4K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$16.2K |
| 3 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$16.2K |
| 4 |
SCM
Saba Capital Management
New York
|
+$15.8K |
| 5 |
QGA
Q Global Advisors
Fort Worth,
Texas
|
+$9.01K |
Top Sellers
SMIHW Hedge Fund Activity: Q2 2022 in Review
24 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Summit Healthcare Acquisition Corp. Warrant (SMIHW) for Q2 2022, worth a combined $18.9M — up 11% from $17.1M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new SMIHW positions and 1 closed out — a net gain of 5 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Athos Capital, opening a new position worth an estimated $24.4K.
- 24 institutional investors held Summit Healthcare Acquisition Corp. Warrant (SMIHW) as of Q2 2022, up from 19 in Q1 2022.
- Funds reported $18.9M of Summit Healthcare Acquisition Corp. Warrant stock for Q2 2022, up 11% quarter-over-quarter.
- 6 funds opened new Summit Healthcare Acquisition Corp. Warrant positions in Q2 2022 and 1 closed out, a net change of +5 holders.
- The largest Summit Healthcare Acquisition Corp. Warrant buyer in Q2 2022 was Athos Capital, an estimated $24.4K added.
Based on aggregated 13F filings for Q2 2022.